Limits...
HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property.

Cogoi S, Shchekotikhin AE, Xodo LE - Nucleic Acids Res. (2014)

Bottom Line: We have previously found that these G-quadruplexes bind to the zinc-finger transcription factors MAZ and Sp1.We also discovered that the two G-quadruplexes are strong targets for small anticancer molecules.In contrast, when one of the two G-quadruplexes was abrogated by point mutations, ATPD-1 repressed transcription by only 50%.

View Article: PubMed Central - PubMed

Affiliation: Department of Medical and Biological Sciences, School of Medicine, P.le Kolbe 4, 33100 Udine, Italy.

Show MeSH

Related in: MedlinePlus

(A) Structure of ATPD-1 and scheme of the transfection experiment. T24 cells were treated with ATPD-1 for 24 h, then transfected with luciferase vector. Right panel shows the dual luciferase assay in T24 cells treated with increasing amounts of ATPD-1 (2.5 and 5 μM) and transfected with wild-type pHRAS-luc or mutant Mut-1, Mut-2, Mut-A, Mut-B, Mut-C and Mut-D; (B) EMSA showing the binding of MAZ-GST (2 μg) to 20 nM quadruplex hras-1 in binding buffer containing increasing amounts of ATPD-1 (r = 0, 1, 2, 4, 6 and 8); (C) FRET-melting of 200 nM hras-1 after overnight incubation in 50 mM KCl and ATPD-1 at r = 0, 1, 2, 4, 6, 8; (D) FRET-melting curves of hras-1 (200 nM) treated with ATPD-1 (r = 0, 1, 2, 4, 6, 8) and MAZ-GST (400 nM); (E) as in D, but with 800 nM MAZ-GST. The curves in (B), (D) and (E) have been normalized to the fluorescence at 80°C (or 85°C).
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4117790&req=5

Figure 8: (A) Structure of ATPD-1 and scheme of the transfection experiment. T24 cells were treated with ATPD-1 for 24 h, then transfected with luciferase vector. Right panel shows the dual luciferase assay in T24 cells treated with increasing amounts of ATPD-1 (2.5 and 5 μM) and transfected with wild-type pHRAS-luc or mutant Mut-1, Mut-2, Mut-A, Mut-B, Mut-C and Mut-D; (B) EMSA showing the binding of MAZ-GST (2 μg) to 20 nM quadruplex hras-1 in binding buffer containing increasing amounts of ATPD-1 (r = 0, 1, 2, 4, 6 and 8); (C) FRET-melting of 200 nM hras-1 after overnight incubation in 50 mM KCl and ATPD-1 at r = 0, 1, 2, 4, 6, 8; (D) FRET-melting curves of hras-1 (200 nM) treated with ATPD-1 (r = 0, 1, 2, 4, 6, 8) and MAZ-GST (400 nM); (E) as in D, but with 800 nM MAZ-GST. The curves in (B), (D) and (E) have been normalized to the fluorescence at 80°C (or 85°C).

Mentions: Given their critical role in transcription regulation, the two neighboring G-quadruplexes can be targeted by small ligands in order to downregulate HRAS: an oncogene playing a key role in the pathogenesis of urinary bladder cancer (5,6,33,34). These molecules should bind preferentially G4-DNA instead of B-DNA, and consequently repress transcription by increasing the stability of the G-quadruplexes. This should inhibit the unfolding of the quadruplex by MAZ and arrests cell growth. To support these hypotheses, we used an antrathiophenedione (ATPD-1), which was recently found to strongly bind to hras-1 (KD of 0.34 ± 0.07, ΔTM of 12 and 22°C, in 100 mM KCl) and hras-2 (KD of 0.27 ± 0.02, ΔTM of 19°C, in 10 mM KCl) quadruplexes (35). We first treated T24 cancer cells with ATPD-1 for 24 h, then with the expression vectors for further 48 h. At the end of the incubation a dual luciferase assay was carried out. The relative firefly luciferase values obtained with wild-type and mutant plasmids, in absence and presence of 2.5 and 5 μM ATPD-1, are reported in the histogram of Figure 8A. It shows that ATPD-1 completely represses, in a dose-response manner, luciferase of wild-type plasmid pHRAS-luc, bearing both HRAS quadruplex-forming motifs. In contrast, the ligand reduced by ∼50% the luciferase expressed by mutants Mut-1 and Mut-2, which bear only one quadruplex-forming motif. This suggests that only one G-quadruplex is unable to block transcription completely. As we expected, Mut-A and Mut-B being unable to form any G-quadruplex, do not respond to ATPD-1. Instead Mut-C and Mut-D respond to the ligand, as they have one quadruplex-forming motif (hras-1).


HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property.

Cogoi S, Shchekotikhin AE, Xodo LE - Nucleic Acids Res. (2014)

(A) Structure of ATPD-1 and scheme of the transfection experiment. T24 cells were treated with ATPD-1 for 24 h, then transfected with luciferase vector. Right panel shows the dual luciferase assay in T24 cells treated with increasing amounts of ATPD-1 (2.5 and 5 μM) and transfected with wild-type pHRAS-luc or mutant Mut-1, Mut-2, Mut-A, Mut-B, Mut-C and Mut-D; (B) EMSA showing the binding of MAZ-GST (2 μg) to 20 nM quadruplex hras-1 in binding buffer containing increasing amounts of ATPD-1 (r = 0, 1, 2, 4, 6 and 8); (C) FRET-melting of 200 nM hras-1 after overnight incubation in 50 mM KCl and ATPD-1 at r = 0, 1, 2, 4, 6, 8; (D) FRET-melting curves of hras-1 (200 nM) treated with ATPD-1 (r = 0, 1, 2, 4, 6, 8) and MAZ-GST (400 nM); (E) as in D, but with 800 nM MAZ-GST. The curves in (B), (D) and (E) have been normalized to the fluorescence at 80°C (or 85°C).
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4117790&req=5

Figure 8: (A) Structure of ATPD-1 and scheme of the transfection experiment. T24 cells were treated with ATPD-1 for 24 h, then transfected with luciferase vector. Right panel shows the dual luciferase assay in T24 cells treated with increasing amounts of ATPD-1 (2.5 and 5 μM) and transfected with wild-type pHRAS-luc or mutant Mut-1, Mut-2, Mut-A, Mut-B, Mut-C and Mut-D; (B) EMSA showing the binding of MAZ-GST (2 μg) to 20 nM quadruplex hras-1 in binding buffer containing increasing amounts of ATPD-1 (r = 0, 1, 2, 4, 6 and 8); (C) FRET-melting of 200 nM hras-1 after overnight incubation in 50 mM KCl and ATPD-1 at r = 0, 1, 2, 4, 6, 8; (D) FRET-melting curves of hras-1 (200 nM) treated with ATPD-1 (r = 0, 1, 2, 4, 6, 8) and MAZ-GST (400 nM); (E) as in D, but with 800 nM MAZ-GST. The curves in (B), (D) and (E) have been normalized to the fluorescence at 80°C (or 85°C).
Mentions: Given their critical role in transcription regulation, the two neighboring G-quadruplexes can be targeted by small ligands in order to downregulate HRAS: an oncogene playing a key role in the pathogenesis of urinary bladder cancer (5,6,33,34). These molecules should bind preferentially G4-DNA instead of B-DNA, and consequently repress transcription by increasing the stability of the G-quadruplexes. This should inhibit the unfolding of the quadruplex by MAZ and arrests cell growth. To support these hypotheses, we used an antrathiophenedione (ATPD-1), which was recently found to strongly bind to hras-1 (KD of 0.34 ± 0.07, ΔTM of 12 and 22°C, in 100 mM KCl) and hras-2 (KD of 0.27 ± 0.02, ΔTM of 19°C, in 10 mM KCl) quadruplexes (35). We first treated T24 cancer cells with ATPD-1 for 24 h, then with the expression vectors for further 48 h. At the end of the incubation a dual luciferase assay was carried out. The relative firefly luciferase values obtained with wild-type and mutant plasmids, in absence and presence of 2.5 and 5 μM ATPD-1, are reported in the histogram of Figure 8A. It shows that ATPD-1 completely represses, in a dose-response manner, luciferase of wild-type plasmid pHRAS-luc, bearing both HRAS quadruplex-forming motifs. In contrast, the ligand reduced by ∼50% the luciferase expressed by mutants Mut-1 and Mut-2, which bear only one quadruplex-forming motif. This suggests that only one G-quadruplex is unable to block transcription completely. As we expected, Mut-A and Mut-B being unable to form any G-quadruplex, do not respond to ATPD-1. Instead Mut-C and Mut-D respond to the ligand, as they have one quadruplex-forming motif (hras-1).

Bottom Line: We have previously found that these G-quadruplexes bind to the zinc-finger transcription factors MAZ and Sp1.We also discovered that the two G-quadruplexes are strong targets for small anticancer molecules.In contrast, when one of the two G-quadruplexes was abrogated by point mutations, ATPD-1 repressed transcription by only 50%.

View Article: PubMed Central - PubMed

Affiliation: Department of Medical and Biological Sciences, School of Medicine, P.le Kolbe 4, 33100 Udine, Italy.

Show MeSH
Related in: MedlinePlus